The Michael Report: 5 Minutes on Employer-Sponsored Healthcare

By Michael Clark

May 2025

With 10 years of experience in the insurance and healthcare industry, I’ve had the privilege of working alongside some of the brightest minds in the field. 

Over the years, I’ve met with over 500 different organizations and personally consulted with more than 100 companies, ranging in size from 30 employees to 5,000. My passion for what I do drives me to continuously find innovative solutions that help businesses take care of their most important asset – their people. 

My goal for this newsletter is to keep it brief and to give you 2-3 valuable takeaways every other week, helping you stay informed and make the best decisions for your business and your employees. 

Proposed 25% tariffs on imported drugs, primarily from Europe, could add nearly $51 billion annually to U.S. drug costs. This could lead to higher out-of-pocket expenses for patients, adding additional financial strain to households. Read the full article from Consumer Affairs. 

Learn more about the differences between Generic vs. Designer Drugs and the common misconceptions surrounding generics. The FDA ensures that generic drugs meet the same standards for dosage, safety, effectiveness, and quality as their branded counterparts. 

CANARX 

CANARX is an International Prescription Service Provider (IPSP) that collaborates with public and private entities to manage companies’ self-funded health plans and work towards saving members millions on prescription drugs. How? It works with pharmacies in Canada, the United Kingdom, and Australia to deliver brand-name medications directly to participants. Learn about how you can benefit from CANARX here.